Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Aurélie Dobric

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1938-8263; OpenAlex author ID A5046347197. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 3

  1. E-Cadherin Is a Structuring Component of Invadopodia in Pancreatic Cancer. Co-author DOI 10.1111/jcmm.70608↗
  2. Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma. First author DOI 10.1038/bjc.2017.411↗
  3. Ribonuclease MCPiP1 contributes to the loss of micro-RNA-200 family members in pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.26310↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Juan Iovanna · 3 shared papers, 2018–2025 · strength 0.39
  2. Philippe Soubeyran · 2 shared papers, 2018–2025 · strength 0.32
  3. Frederic André · 2 shared papers, 2018–2025 · strength 0.31
  4. Nelson Dusetti · 2 shared papers, 2018–2025 · strength 0.31
  5. Carole Siret · 2 shared papers, 2018 · strength 0.15
  6. Dominique Lombardo · 2 shared papers, 2018 · strength 0.15
  7. Françoise Boudouresque · 1 shared paper, 2018 · strength 0.09
  8. Yolande Berthois · 1 shared paper, 2018 · strength 0.09
  9. Աննա Մարտիրոսյան · 1 shared paper, 2018 · strength 0.07
  10. Richard Tomasini · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.